These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 629093

  • 1. [Behavior of the complement components C3 and C4, C-reactive protein and blood sedimentation rate for activity control in arthritis patients during thermo-hydrotherapy].
    Günther R, Spath P, Egg D, Geier W, Nachbauer E.
    Z Rheumatol; 1978; 37(1-2):33-9. PubMed ID: 629093
    [Abstract] [Full Text] [Related]

  • 2. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
    Stojan B.
    Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
    [Abstract] [Full Text] [Related]

  • 3. [Serum immunoglobulin patterns in rheumatoid arthritis].
    Dreher R.
    Z Rheumatol; 1977; 36(1-2):3-21. PubMed ID: 842145
    [Abstract] [Full Text] [Related]

  • 4. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation.
    Dernellis J, Panaretou M.
    Am J Cardiol; 2006 Jan 15; 97(2):245-8. PubMed ID: 16442371
    [Abstract] [Full Text] [Related]

  • 5. [Rheumatoid pericarditis: correlation with immunologic parameters].
    Alusík S, Skalická H, Vencovský J, Kohoutová M.
    Vnitr Lek; 1995 Nov 15; 41(11):764-6. PubMed ID: 8553595
    [Abstract] [Full Text] [Related]

  • 6. [Complement (C3 and C4) in patients with rheumatoid arthritis during 6 months of treatment with gold salts].
    Vlak T, Jajić I.
    Reumatizam; 1992 Nov 15; 39(1):7-10. PubMed ID: 1366144
    [Abstract] [Full Text] [Related]

  • 7. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE, Elmgreen J, Teisner B, Svehag SE.
    Acta Med Scand; 1988 Nov 15; 223(6):557-60. PubMed ID: 3389208
    [Abstract] [Full Text] [Related]

  • 8. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
    Familian A, Voskuyl AE, van Mierlo GJ, Heijst HA, Twisk JW, Dijkmans BA, Hack CE.
    Ann Rheum Dis; 2005 Jul 15; 64(7):1003-8. PubMed ID: 15958758
    [Abstract] [Full Text] [Related]

  • 9. [No difference in effectiveness measured between treatment in a thermal bath and in an exercise bath in patients with rheumatoid arthritis].
    Landewé RB, Peeters R, Verreussel RL, Masek BA, Goei The HS.
    Ned Tijdschr Geneeskd; 1992 Jan 25; 136(4):173-6. PubMed ID: 1736128
    [Abstract] [Full Text] [Related]

  • 10. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I, Nikolov K, Petrova P.
    Vutr Boles; 1987 Jan 25; 26(4):66-70. PubMed ID: 3499707
    [Abstract] [Full Text] [Related]

  • 11. [Changes of the blood sialic acid content and acute phase reactants in open heart surgery].
    Chikakiyo H, Oshima I, Kohama T, Nagata J, Yamazaki R, Bando M, Murakami K.
    Rinsho Byori; 1983 Mar 25; Suppl 54():89-95. PubMed ID: 6193299
    [No Abstract] [Full Text] [Related]

  • 12. Immunologic evaluation of rheumatoid arthritis and therapy with levamisole.
    Verhaegen H, de Cree J, de Cock W, Schuermans Y, Engels M, Sonck W.
    Biomedicine; 1977 Jul 25; 26(4):283-91. PubMed ID: 922113
    [Abstract] [Full Text] [Related]

  • 13. [A comparative study of serum complement (C3 and C4) in inflammatory joint diseases].
    Dacheva V, Dimov DM, Nedialkova V, Koleva P.
    Vutr Boles; 1990 Jul 25; 29(5):68-74. PubMed ID: 1706901
    [Abstract] [Full Text] [Related]

  • 14. [Fibronectin and other immunologic parameters in chronic polyarthritis].
    Siegmeth W, Minar E, Graninger W, Pirich K, Zazgornik J.
    Z Rheumatol; 1984 Jul 25; 43(1):27-9. PubMed ID: 6201023
    [Abstract] [Full Text] [Related]

  • 15. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
    Mallya RK, de Beer FC, Berry H, Hamilton ED, Mace BE, Pepys MB.
    J Rheumatol; 1982 Jul 25; 9(2):224-8. PubMed ID: 7097681
    [Abstract] [Full Text] [Related]

  • 16. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
    Vlak T, Jajić Z.
    Reumatizam; 1992 Jul 25; 39(1):19-22. PubMed ID: 1366140
    [Abstract] [Full Text] [Related]

  • 17. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
    Molenaar ET, Voskuyl AE, Familian A, van Mierlo GJ, Dijkmans BA, Hack CE.
    Arthritis Rheum; 2001 May 25; 44(5):997-1002. PubMed ID: 11352263
    [Abstract] [Full Text] [Related]

  • 18. [Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].
    Rondier J, Cayla J, Tron F, Roger M, Bach JF.
    Nouv Presse Med; 1978 Oct 07; 7(34):3023-7, 3029-30. PubMed ID: 364409
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
    Wouters D, Voskuyl AE, Molenaar ET, Dijkmans BA, Hack CE.
    Arthritis Rheum; 2006 Apr 07; 54(4):1143-50. PubMed ID: 16572449
    [Abstract] [Full Text] [Related]

  • 20. Complement activation in acute coronary syndromes.
    Iltumur K, Karabulut A, Toprak G, Toprak N.
    APMIS; 2005 Mar 07; 113(3):167-74. PubMed ID: 15799759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.